Precision medicine is a technique for doctors to deliver and plan personalised care for their patients based on their genetics (or the genes in their cancer cells). It's also known as personalized medicine or personalized care. Precision medicine examines how a specific gene change (gene mutation) may affect a person's likelihood of developing a specific cancer, or how their genes (or genes in their cancer cells) may affect treatment if they already have cancer. Precision medicine is being used to determine which tests and treatments are best for certain cancers. Of course, the goal is to develop more precise medicine that reduces side effects while increasing therapeutic impact. However, the last 20 years have been marked by sophisticated scientific conceptual achievements that have been overshadowed by a lack of attention to the fundamental building blocks of implementation and the realities of patient care. Precision oncology will continue to make scientific advancements, but in order to make real changes for patients, worldwide collaboration and a holistic approach to the patient that extends beyond the lab are essential.
Title : Copper (II) complexes as potential anticancer agents
Salah S Massoud, University of Louisiana, United States
Title : Pharmacogenomics: current status and future directions
Matthias Schwab, University of Tübingen, Germany
Title : Talus bone of the hindfoot: Unique anatomy and an important clinical implication
Abdelmonem Awad Hegazy, Zarqa University, Jordan
Title : The use of anti seizure medication therapeutic blood level determination to personalise the treatment of epileptic seizures especially in patients attending the accident and emergency department
Roy Gary Beran, University of New South Wales, Australia
Title : Effect of Fluvoxamine on Interluekin-6 level of COVID-19 patients, hospitalized in ICU: A randomized clinical trial
Mitra Safa, Shahid Beheshti University of Medical Sciences, Iran (Islamic Republic of)
Title : Precision Treatment of Alzheimer's
Boris Tankhilevich, Magtera, Inc., United States